Vancomycin in Oregon: Who's using it and why

被引:15
作者
Cieslak, PR
Strausbaugh, LJ
Fleming, DW
Ling, JM
机构
[1] Oregon Hlth Div, Portland, OR 97232 USA
[2] Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, State Branch, Prevent Med Residency Epidemiol Program Off, Atlanta, GA USA
[3] Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA
[4] Assoc Profess Infect Control & Epidemiol, Portland, OR USA
关键词
D O I
10.1086/501669
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To determine the proportion of vancomycin orders that are appropriate according to national guidelines and to identify targets for educational messages. DESIGN: Population-based study of vancomycin use in Oregon during a 3-week period. Survey of pharmacists, prospective nagging of vancomycin orders, and data abstraction from patient charts using standardized forms. SETTING: Nonpsychiatric hospitals in Oregon. RESULTS: Four (6%) of the 66 Oregon hospitals had pharmacy restrictions on initial vancomycin orders. Sixty-four (97%) of the hospitals participated in the study of indications for use; 293 vancomycin orders were reported; 3.8 courses were initiated per 1,000 patient-days. Indications for use were determined for 266 (91%); of these, 159 (60%) were deemed appropriate. Of uses for prophylaxis, empirical treatment of suspected gram-positive infection, and treatment of documented grampositive infection, 57%, 56%, and 65%, respectively, were appropriate. Of hospitals with <250, 251-475, and >475 licensed beds, 65%, 58%, and 57% of vancomycin orders were appropriate. No single medical specialty accounted for >16% of inappropriate vancomycin use. CONCLUSIONS: Vancomycin was used inappropriately by physicians of many different specialties, in hospitals of all sizes, and in sundry clinical situations. The problem of inappropriate vancomycin use does not lend itself to solution by educational strategies targeted at specific subgroups; restrictions by hospital pharmacies may be required.
引用
收藏
页码:557 / 560
页数:4
相关论文
共 21 条
[1]   Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium [J].
Anglim, AM ;
Klym, B ;
Byers, KE ;
Scheld, WM ;
Farr, BM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (10) :1132-1136
[2]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[3]  
[Anonymous], MORB MORTAL WKLY REP
[4]  
Beidas S, 1996, INFECT CONT HOSP EP, V17, P773
[5]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
[6]  
Duncan RA, 1997, INFECT CONT HOSP EP, V18, P260
[7]   THE EPIDEMIOLOGY OF INTRAVENOUS VANCOMYCIN USAGE IN A UNIVERSITY HOSPITAL - A 10-YEAR STUDY [J].
ENA, J ;
DICK, RW ;
JONES, RN ;
WENZEL, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (05) :598-602
[8]  
Evans ME, 1996, INFECT CONT HOSP EP, V17, P356
[9]   Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership [J].
Goldmann, DA ;
Weinstein, RA ;
Wenzel, RP ;
Tablan, OC ;
Duma, RJ ;
Gaynes, RP ;
Schlosser, J ;
Martone, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :234-240